Active Not RecruitingNCT06832462
This study is looking at whether a digital support tool can help people with Mental Health, Mental Health Issues, or Anxiety. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
DepressionBehavioralOver 18 Years
- Countries
- Malaysia
- Sponsor
- Universiti Teknologi Malaysia
- Condition
- Depression
RecruitingNCT03887715
This study is looking at whether a digital support tool can help people with Treatment Resistant Depression. Participants take part in a digital support tool and complete follow-up assessments.
DepressionOtherOver 18 Years
- Countries
- United States
- Sponsor
- LivaNova
- Condition
- Depression
RecruitingNCT06005103
This study is comparing Treatment with MoodHeadBand (T-PEMF treatment) with placebo for people with Moderate Depression, Severe Depressive Episode Without Psychotic Symptoms, Recurrent depression, Current Episode Moderate, or Recurrent depression, Current Episode Severe Without Psychotic Symptoms. Participants receive Treatment with MoodHeadBand (T-PEMF treatment) or placebo and complete study visits and assessments.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- Denmark
- Sponsor
- Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
- Condition
- Depression
Not Yet RecruitingNCT06894641
This study is looking at whether cognitive behavioural therapy can help people with Major Depression. Participants take part in cognitive behavioural therapy and complete follow-up assessments.
DepressionBehavioralOver 65 Years
- Countries
- Global
- Sponsor
- Nova Scotia Health Authority
- Condition
- Depression
RecruitingNCT04223115
This study is looking at whether cognitive behavioural therapy can help people with Depression or Antenatal Depression. Participants take part in cognitive behavioural therapy and complete follow-up assessments.
DepressionBehavioralFrom 18 Years to 55 Years
- Countries
- Finland
- Sponsor
- University of Turku
- Condition
- Depression
Active Not RecruitingNCT07102017
This study is looking at whether Co-Design LOVOT Intervention can help people with Loneliness, Well-Being, Psychological, or Depression - depression. Participants take part in Co-Design LOVOT Intervention and complete follow-up assessments.
DepressionDeviceOver 65 Years
- Countries
- China
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Condition
- Depression
Not Yet RecruitingNCT07482852
This study is looking at whether VR social musical exergame can help people with Depression or Anxiety. Participants take part in VR social musical exergame and complete follow-up assessments.
DepressionOtherFrom 18 Years to 25 Years
- Countries
- Global
- Sponsor
- Hunan University of Traditional Chinese Medicine
- Condition
- Depression
Enrolling By InvitationNCT06383221
This study is looking at how "Mental Fitness Boot Camp - Advanced Counseling" Step-by-Step Care works for people with Perinatal Depression, Stepped Care, or Perinatal Anxiety in routine care. Participants take part in "Mental Fitness Boot Camp - Advanced Counseling" Step-by-Step Care and complete follow-up assessments.
DepressionOtherOver 18 Years
- Countries
- China
- Sponsor
- Fangbiao Tao
- Condition
- Depression
RecruitingNCT06072898
This study is comparing Psilocybin with placebo for people with depression. Participants receive Psilocybin or placebo and complete study visits and assessments.
DepressionOtherFrom 18 Years to 64 Years
- Countries
- Canada
- Sponsor
- Sunnybrook Health Sciences Centre
- Condition
- Depression
RecruitingNCT06906939
This study is looking at whether a digital support tool can help people with Knee Osteoarthritis or Depression. Participants take part in a digital support tool and complete follow-up assessments.
DepressionOtherFrom 50 Years to 95 Years
- Countries
- United States
- Sponsor
- University of California, Los Angeles
- Condition
- Depression
RecruitingNCT06775379
This study is comparing Azetukalner, an experimental Kv7 potassium-channel opener, with placebo for people with depression. Participants receive Azetukalner or placebo and complete study visits and assessments.
DepressionDrugFrom 18 Years to 74 Years
- Countries
- United States
- Sponsor
- Xenon Pharmaceuticals Inc.
- Condition
- Depression
RecruitingNCT07076407
This study is comparing Azetukalner, an experimental Kv7 potassium-channel opener, with placebo for people with depression. Participants receive Azetukalner or placebo and complete study visits and assessments.
DepressionOtherFrom 18 Years to 74 Years
- Countries
- Finland, Poland, Romania, Slovakia, United States
- Sponsor
- Xenon Pharmaceuticals Inc.
- Condition
- Depression
Not Yet RecruitingNCT07227103
This study is looking at whether ONE-D TMS can help people with Treatment Resistant Depression. Participants receive a study treatment and complete follow-up visits and assessments.
DepressionDrugFrom 18 Years to 80 Years
- Countries
- United States
- Sponsor
- NeuroRx, Inc.
- Condition
- Depression
Not Yet RecruitingNCT06749470
This study is comparing Jieyu Chufan Capsules with Control Group for people with depression. Participants receive Jieyu Chufan Capsules or Control Group and complete study visits and assessments.
DepressionDrugFrom 18 Years to 65 Years
- Countries
- Global
- Sponsor
- Central South University
- Condition
- Depression
UnknownNCT05526235
This study is looking at whether questionnaires and follow-up can help people with Depression, Anxiety, or Psychological Distress. Participants take part in the program and complete follow-up questionnaires or assessments.
DepressionBehavioralFrom 18 Years to 65 Years
- Countries
- Spain
- Sponsor
- Fundació Sant Joan de Déu
- Condition
- Depression
CompletedNCT05841030
This observational study is following people with major depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
DepressionOtherFrom 18 Years to 74 Years
- Countries
- Argentina, Brazil, Canada, France, Germany, Italy, South Korea, Spain, Sweden, United Kingdom, United States
- Sponsor
- Janssen Research & Development, LLC
- Condition
- Depression
Active Not RecruitingNCT03642964
This study is comparing CTC-501 with placebo for people with depression. Participants receive CTC-501 or placebo and complete study visits and assessments.
DepressionDrugFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Chase Therapeutics Corporation
- Condition
- Depression
TerminatedNCT05518149
This study is looking at whether Aticaprant can help people with major depression. Participants take part in Aticaprant and complete follow-up assessments.
DepressionOtherFrom 18 Years to 74 Years
- Countries
- Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, France, Hungary, Italy, Poland, Portugal, Slovakia, South Africa, South Korea, Spain, Sweden, Taiwan, United Kingdom, United States
- Sponsor
- Janssen Research & Development, LLC
- Condition
- Depression
RecruitingNCT07412756
This study is comparing Brenipatide with placebo for people with major depression. Participants receive Brenipatide or placebo and complete study visits and assessments.
DepressionOtherFrom 18 Years to 75 Years
- Countries
- Australia, Brazil, Canada, China, Germany, Greece, Japan, Mexico, Poland, United States, South Korea, Spain, Taiwan, United Kingdom
- Sponsor
- Eli Lilly and Company
- Condition
- Depression
RecruitingNCT07053345
This study is looking at evaluate how well esketamine nasal spray works in improving depressive symptoms in participants with treatment resistant depression (TRD) for people with depression, Treatment-Resistant. Taking part may give some people access to Esketamine 56 mg, but direct benefit is not guaranteed.
DepressionOtherFrom 18 Years to 64 Years
- Countries
- South Korea
- Sponsor
- Janssen Korea, Ltd., Korea
- Condition
- Depression
RecruitingNCT05803551
This study is looking at care and outcomes for people with Depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
DepressionDrugFrom 18 Years to 99 Years
- Countries
- United States
- Sponsor
- Mayo Clinic
- Condition
- Depression
RecruitingNCT05599126
This study is looking at whether Mianserin can help people with Depression. Participants receive a study treatment and complete follow-up visits and assessments.
DepressionDrugFrom 18 Years to 60 Years
- Countries
- China
- Sponsor
- Zhenghui YI
- Condition
- Depression
Active Not RecruitingNCT06792136
This study is looking at care and outcomes for people with depression (depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- Japan
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Condition
- Depression
Enrolling By InvitationNCT07000799
This study is looking at be conducted at elementary schools in Oslo and aims to explore multiple aspects of school absenteeism and student well-being for people with School Absenteeism or Anxiety and Depression. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
DepressionBehavioralFrom 8 Years to 13 Years
- Countries
- Norway
- Sponsor
- University of Oslo
- Condition
- Depression
RecruitingNCT07204314
This study is comparing Vortioxetine tablets with placebo for people with depression. Participants receive Vortioxetine tablets or placebo and complete study visits and assessments.
DepressionOtherFrom 12 Years to 17 Years
- Countries
- Japan
- Sponsor
- Takeda
- Condition
- Depression
